Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
John Fanikos, Director of Strategic Initiatives at North American Thrombosis Forum, shared a post on LinkedIn:
“Once again the hard work of the Thrombosis Research Group is making the news.
Superficial Vein Thrombosis (in contrast to deep vein thrombosis) has represented a treatment challenge for clinicians. In this review, blood clot size (> 5 centimeters) and location (<3 centimeters from a deep vein) matters.
This directs the treatment choice of anticoagulation (fondaparinux, rivaroxaban) versus conservative management (warm compresses, ibuprofen, compression stockings).
Kudos to the clinicians, Drs. Piazza, Krishnathasan, Hamade, Ujueta, Scimeca, Goldhaber, Bikdeli et al. Thank you for including me.
You can visit the Vasculearn Network and find stories from patients on the Discussion Board about their diagnosis and treatment journey.”
Title: Superficial Vein Thrombosis
Authors: Gregory Piazza, Darsiya Krishnathasan, Nada Hamade, Francisco Ujueta, Giovanni Scimeca, Marcos D. Ortiz-Rios, Bridget McGonagle, Jean-Philippe Galanaud, David Jiménez, Manuel Monreal, John Fanikos, Anahita Dua, Leben Tefera, Raghu Kolluri, Sahil A. Parikh, Walter Ageno, Samuel Z. Goldhaber, Jeffrey I. Weitz, Lisa K. Moores, Isabelle Quéré, Behnood Bikdeli
Read the full article here.
Stay updated on the latest news in the field of thrombosis with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show